Fig. 4From: Effect of sofosbuvir plus daclatasvir on virological response and liver function tests as a line of treatment for HCV related cirrhosis (a prospective cohort study)Change in INR during and post-treatment of the studied patients. P value < 0.001; INR, international normalization ratioBack to article page